- Head Injuries Are a Growing Risk for Anesthesiologists, Experts Warn
- Where Have All The Insects Gone — And Why?
- HHS Announces Plans to Pay Moderna $176 Million for mRNA Flu Vaccine
- Novavax COVID Vaccine Moves Closer to Full FDA Approval
- Nearly Half of Americans Breathe Unhealthy Air, New Report Finds
- California Gives $25 Gift Cards To Boost Bird Flu Testing
- Four-Gene Combo Might Predict Lethality Of Stomach Cancer
- Blood Test Can Predict Fatty Liver Disease
- These Three Bad Habits Can Harm Your Health As Young As Your Mid-30s
- Umbilical Cord Could Contain Clues For Child’s Future Health
Perjeta Approved for Early Stage Breast Cancer
MONDAY, Sept. 30The anti-cancer drug Perjeta (pertuzumab) has been approved by the U.S. Food and Drug Administration to treat early-stage breast cancer before surgery, the agency said Monday.
In 2012, the drug was approved to treat advanced or spreading (metastatic) HER-2 positive breast cancer, which is triggered by increased amounts of a protein that fuels the growth of cancer cells, the FDA said in a news release.
The drug’s new use is meant for people with HER-2 positive early-stage breast cancer who are at increased risk of the cancer returning, spreading or of dying from the disease, the agency said. The drug is to be used with in combination with chemotherapy before surgery.
Perjeta’s safety and effectiveness were evaluated for the new use in a clinical study involving 417 people, the FDA said. A “confirmatory” study involving more than 4,800 people is ongoing, with results expected in 2016.
Perjeta is marketed by San Francisco-based Genentech, a member of the Roche Group.
More information
To learn more about this approval, visit the FDA.
Source: HealthDay
Copyright © 2025 HealthDay. All rights reserved.
Related
-
Early Menopause Might Mean Greater Age-Related Brain DeclineEarly menopause could be a warning sign for future...
- April 23, 2025
-
Most Women Are Comfortable With AI-Assisted MammographyWomen are OK with having an AI program help...
- April 22, 2025
-
Most Women Aren’t Clear When Menopause Might Start
Early symptoms of menopause will first appear when many...
- April 11, 2025
-
Bedsores More Likely In Short-Staffed Hospitals Leaning On Nurse OT, Travel NursesHospitals could be short-changing patients if they lean too...
- April 4, 2025
